HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Günter Gisselmann Selected Research

Odorant Receptors (Odorant Receptor)

1/2018Olfactory Receptors as Biomarkers in Human Breast Carcinoma Tissues.
1/2018Characterization of the Olfactory Receptor OR10H1 in Human Urinary Bladder Cancer.
1/2017Odorant Receptor 51E2 Agonist β-ionone Regulates RPE Cell Migration and Proliferation.
1/2017Activation of odorant receptor in colorectal cancer cells leads to inhibition of cell proliferation and apoptosis.
1/2015Monoterpene (-)-citronellal affects hepatocarcinoma cell signaling via an olfactory receptor.
1/2013Human trace amine-associated receptor TAAR5 can be activated by trimethylamine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Günter Gisselmann Research Topics

Disease

4Neoplasms (Cancer)
01/2018 - 01/2010
3Nausea
01/2016 - 01/2015
2Pain (Aches)
09/2020 - 01/2013
2Breast Neoplasms (Breast Cancer)
01/2018 - 01/2016
2Carcinoma (Carcinomatosis)
01/2018 - 01/2016
2Wounds and Injuries (Trauma)
01/2017 - 11/2014
2Prostatic Neoplasms (Prostate Cancer)
01/2017 - 07/2016
2Vomiting
01/2016 - 11/2015
1Muscle Cramp (Cramp)
01/2018
1Sleep-Wake Transition Disorders (Sleep Talking)
01/2018
1Urinary Bladder Neoplasms (Bladder Cancer)
01/2018
1Falciparum Malaria (Plasmodium falciparum Malaria)
01/2018
1Colorectal Neoplasms (Colorectal Cancer)
01/2017
1Skin Diseases (Skin Disease)
01/2017
1Anxiety Disorders (Anxiety Disorder)
01/2016
1Sleep Initiation and Maintenance Disorders (Insomnia)
01/2016
1Necrosis
01/2016
1Psychomotor Agitation (Akathisia)
01/2016
1Triple Negative Breast Neoplasms
01/2016
1Hepatocellular Carcinoma (Hepatoma)
01/2015
1Cachexia
01/2015
1Anosmia
01/2013
1Neuralgia (Stump Neuralgia)
01/2010
1Melanoma (Melanoma, Malignant)
01/2010
1Ganglion Cysts (Ganglion)
10/2003

Drug/Important Bio-Agent (IBA)

6Odorant Receptors (Odorant Receptor)IBA
01/2018 - 01/2013
3ORALIT (ORS)IBA
01/2018 - 01/2017
2Biomarkers (Surrogate Marker)IBA
01/2018 - 01/2018
2Ion Channels (Ion Channel)IBA
01/2013 - 01/2010
1Transient Receptor Potential ChannelsIBA
09/2020
1Quinine (Quinson)FDA Link
01/2018
1Proteins (Proteins, Gene)FDA Link
01/2018
1Chloroquine (Aralen)FDA LinkGeneric
01/2018
1Messenger RNA (mRNA)IBA
01/2018
1Retinal Pigments (Pigments, Visual)IBA
01/2017
1Androgen Receptors (Androgen Receptor)IBA
07/2016
1AndrogensIBA
07/2016
1LigandsIBA
01/2016
1CalciumIBA
01/2016
1Capsaicin (Zostrix)FDA Link
01/2016
1CationsIBA
01/2016
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
01/2016
15-HT3 Serotonin Receptors (5 HT3 Receptor)IBA
11/2015
1citronellalIBA
01/2015
1Terpenes (Terpenoids)IBA
01/2015
1Monoterpenes (Monoterpenoids)IBA
01/2015
1p38 Mitogen-Activated Protein KinasesIBA
01/2015
1liu-jun-zi-tangIBA
01/2015
1pentamethylcyclopent-3-ene-butanolIBA
11/2014
1trimethylamineIBA
01/2013
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2013
1MentholFDA Link
01/2010
1Analgesics (Analgesic Drugs)IBA
01/2010
1Potassium Channels (Potassium Channel)IBA
10/2003
1PotassiumIBA
10/2003

Therapy/Procedure

1Therapeutics
01/2018
1Kampo Medicine (Kampo)
01/2016
1Drug Therapy (Chemotherapy)
11/2015
1Analgesia
01/2010